Ingredient and formulation
Liposomal quercetin
For a quercetin formulation, selecting the delivery system matters alongside the active content. We assess liposomal quercetin projects against the intended product format, analytical documentation and manufacturing conditions.
What is liposomal quercetin?
Quercetin is a flavonoid found in a range of plants. In a liposomal formulation, it is incorporated into a delivery system built from phospholipids. Understanding an ingredient therefore requires more than a quercetin percentage: the carrier composition and evidence of its structure also matter.
Liposomal systems, micelles and phospholipid complexes are different technologies. Findings for one do not define the performance of another. We compare options by identifying the chemical form of quercetin, its active content and the delivery system separately.
From active content to the production plan.
Total quercetin per gram of ingredient is not the same measurement as encapsulated quercetin. Assay, encapsulation efficiency and phospholipid content answer different questions. We examine the analytical method, reporting unit and calculation basis behind each result.
This distinction supports accurate fill-weight and unit-cost calculations, while leaving room for other ingredients. Capsule and sachet development also considers powder flow and moisture; liquid projects require assessment of pH, appearance, taste and sedimentation.
One test does not show the whole picture.
An appropriate HPLC assay helps assess active content. Characterising a liposomal structure requires complementary information on particle size and distribution, morphology, phospholipid composition and encapsulation efficiency.
A laboratory study of quercetin-loaded liposomes combines several techniques to evaluate size and structure. It does not establish greater clinical effectiveness for a commercial ingredient; it illustrates why a technical dossier needs complementary analytical evidence.
Source: Melchior et al., 2023
The ingredient must suit your formulation.
Behaviour after processing and storage matters alongside the initial assay. Research on the preparation and freeze-drying of quercetin liposomes examines manufacturing methods, size distribution and incorporation of the active together.
We therefore plan sample assessment around your actual processing conditions. Heat, mixing, drying, other ingredients and packaging are considered. The finished product’s shelf life must be established through its own stability programme.
Source: Alexopoulou et al., 2006
What we assess in the technical dossier
| Parameter | Information to assess |
|---|---|
| Active identity | Quercetin form, source, assay and reporting unit |
| Carrier composition | Phospholipid source, excipients and allergen information |
| Structure and distribution | Particle size, distribution and available imaging data with the measurement method |
| Lot conformity | CoA, impurity and microbiological results, storage conditions |
| Sourcing plan | Suitable commercial grade, sample scope, annual requirement and target market |
Common questions
How does liposomal quercetin differ from standard quercetin?
Standard quercetin describes the active itself. A liposomal form also requires evaluation of its delivery system. The technical dossier should clearly identify the structure, composition and active content.
Does a liposomal form provide higher bioavailability?
Such a comparison needs an appropriate human study of the selected formulation. Results from another delivery system, or a formulation investigated only in the laboratory, cannot be transferred directly.
How is liposomal structure assessed in a powder?
Structural data are reviewed alongside manufacturing and reconstitution conditions. Powder appearance, water solubility or quercetin assay alone does not demonstrate a liposomal structure.
What should we share for a technical assessment?
Share the intended product format, planned active content, other ingredients, destination market and estimated annual requirement. We can then define the suitable commercial grade, document scope and sample assessment.
Technical library
Better questions. Stronger formulations.
What is liposomal technology? From ingredient to formulation
A Biontera guide to liposomal ingredient structure, the role of phospholipids and the technical evidence used in product development.
Liposomal and water-soluble forms: what is the difference?
Understand the difference between liposomal structure, water solubility and bioavailability when comparing nutraceutical ingredient specifications.
How to read bioavailability studies
A practical guide to AUC, Cmax, active dose and comparators when assessing liposomal ingredient research for product development.
Start with the right ingredient.
Share your product format, destination market and annual requirement. Let’s assess suitable commercial grades, technical documents and the sample process together.